Swiss SCRIPT Interim Findings Suggest Pharmacy Sales and Advice Support Lower-Risk Cannabis Use
SCRIPT interim findings suggest nonprofit pharmacy sales plus advice can encourage potentially lower-risk consumption without observed frequency increases. Existing adult users are randomized to immediate or six-month delayed access. This policy pilot is not a disease-treatment trial or evidence of reduced use in the wider population.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
bern.ch
CannabisInsight selects and summarizes news from external sources. Copyright in the original articles remains with the respective publishers or institutions. Follow the source links for full reporting and context.
Original Link
https://www.bern.ch/mediencenter/medienmitteilungen/aktuell_ptk/cannabis-studie-regulierte-abgabe-beguenstigt-risikoaermeren-konsum